The MMR vaccine: Public health, private fears
The MMR vaccine: Public health, private fears

This free course is available to start right now. Review the full course description and key learning outcomes and create an account and enrol if you want a free statement of participation.

Free course

The MMR vaccine: Public health, private fears

8.7 References for Reading 1

Fitzpatrick, M. (2004) Chapter 8 ‘The Lancet Paper’ taken from MMR and Autism: What Parents Need to Know, London, Routledge. Copyright © 2004 Michael Fitzpatrick.

Note: Internet sites originally accessed between January and December 2003.

Abbasi, K. (2001) ‘Man, mission, rumpus’, British Medical Journal; 322: p.306.

Afzal, M.A., Osterhaus, A.D.M.E., Cosby, S.L., Jin, L., Beeler, J., Takeuchi, K., Kawashima, H. (2003) ‘Comparative evaluation of measles virus-specific RT-PCR methods through an international collaborative study’, Journal of Medical Virology; 70: pp. 171–6.

Allergy Induced Autism (1999) Statement on Taylor et al. 1999, at http://www.whale.to/ vaccines/ aia.html [Tip: hold Ctrl and click a link to open it in a new tab. (Hide tip)] .

Aitken, K.J. (2001b) ‘Q&A’ at http://www.singlevaccines.com/ ken-aitken1.html.

Arlett, P., Bryan, P. (2001) ‘A response to “MMR: through a glass, darkly” by Drs A.J. Wakefield and S.M. Montgomery and published reviewers’ comments’, Adverse Drug Reactions and Toxicological Review; 20 (1): pp. 37–45.

Bandolier (2002) ‘MMR vaccination’ at http://www.jr2.ox.ac.uk/ bandolier/ band84/ MMR.html.

Brown, D.W.G., Jin, L., Ramsay, M. (2002) ‘Comments on abstract submission’, Infectious Diseases in the News (27 June), London: Public Health Laboratory Service (http://www.phls.org.uk/ press).

Calman, K. (1998) ‘MMR vaccine, Crohn's disease and autism’, From the Chief Medical Officer (27 March).

Chen, R.T., DeStefano, F. (1998) ‘Vaccine adverse events: causal or coincidental?’, Lancet; 351: pp.611–12.

Dealler, S. (2001) ‘MMR and toxicology’, Adverse Drug Reactions and Toxicology Review; 20(1): pp.55–7.

Elliman, D., Bedford, H. (2001) ‘MMR vaccine: the continuing saga’, British Medical Journal; 322: pp. 183–4.

Finn, A. (2002) ‘MMR vaccine debate: competing interests need to be declared’ (Letter), British Medical Journal; 324: pp.734–5.

Fitzpatrick, M. (1998) ‘How now mad cow?’ in I. McCalman with B. Penny and M. Cook (eds.), Mad Cows and Modernity: Cross disciplinary reflections on the crisis of Creutzfeldt-Jakob Disease, Humanities Research Centre Monograph Series No. 13, Canberra: Australian National University.

Fletcher, A.P. (2000) ‘Referee 3’ (comments on ‘MMR vaccine: through a glass darkly’ by A.J. Wakefield and S.M. Montgomery) Adverse Drug Reactions and Toxicology Reviews; 19 (4): pp.288–91.

Galambos, L. (1999) ‘A century of innovation in vaccines’, Vaccine; 17: S7–10.

Gallagher, R. (2003) ‘Vaccination undermined’, The Scientist; 17 (22) (17 November): p.6.

Halsey, N.A. et al. (2001) ‘MMR vaccine and autistic spectrum disorder: a report from the new challenges in childhood immunisation conference’, Paediatrics; 107(5): e84.

Horton, R. (2003) Second Opinion: Doctors, diseases and decisions in modern medicine, London: Granta.

Institute of Medicine (2003) Financing Vaccines in the 21st Century: Assuring access and availability, Washington, DC: National Academy of Sciences.

Lindley, K.J., Milla, P.J. (1998) ‘Autism, inflammatory bowel disease, and MMR vaccine’ (Correspondence), Lancet; 351: p.907.

Madsen, K.M., Hvidd, A., Vestergaard, M., Schendel, D., Wohlfart, J., Thorsen, P., Olsen, J., Melbye, M. (2002) ‘A population-based study of MMR vaccine and autism’, New England Journal of Medicine; 347: pp. 1477–82.

Miller, D.L., Madge, N., Diamond, J., Wadsworth, J., Ross, E. (1993) ‘Pertussis immunisation and serious acute neurological illnesses in children’, British Medical Journal; 307: pp.1171–6.

Miller, E., Andrews, N. (2001) ‘Comments on “MMR: through a glass darkly” (http://www.phls.co.uk/ facts/ Vaccination/ 012201wakefield.htm).

Mills, H. (2002) MMR: The story so far, Private Eye Special Report, London: Private Eye.

Moses, V. (2002) ‘Chewing over GM food’, spiked-online, 5 February, http://www.spiked-online.com/ Articles/ 00000002D3EF.htm.

Moynihan, R., Heath I., Henry D. (2002) ‘Selling Sickness: The pharmaceutical industry and disease mongering’, British Medical Journal; 324:pp.886–91.

MRC (Medical Research Council) (1998) ‘Group concluded no reason for change in MMR vaccine policy’, Press Release Ref: 09/98, London: MRC.

Murch, S., Thomson, M., Walker-Smith, J.A. (1998) ‘Autism, inflammatory bowel disease, and MMR vaccine’ (Correspondence: authors’ reply), Lancet; 351: p.908.

O'Leary, J.J. (2002a) ‘Link found between measles virus and gut abnormalities in children with developmental disorder’ (Press Statement) (see mp.bmjjournals.com/cgi/content/full/54/DC1).

Peltola, H. Patja, A., Leinikki, P., Valle, M., Davidkin, I., Paunio, M. (1998) ‘No evidence for MMR vaccine-associated inflammatory bowel disease or autism in a 14-year prospective study’, Lancet; 351: pp.1327–8.

Phillips, M. (2003) ‘MMR: the truth’, Daily Mail, 11–13 March.

Richmond, P., Goldblatt, D. (1998) ‘Autism, inflammatory bowel disease, and MMR vaccine’ (Correspondence), Lancet; 351: p. 1355.

Shiels, O., Smyth, P., Martin, C., O'Leary, J.J. (2002) ‘Development of an ‘allelic discrimination’ type assay to differentiate between the strain origins of measles virus detected in intestinal tissue of children with ileocolonic lymphonodular hyperplasia and concomitant developmental disorder’. Abstract (No 20) presented at Pathological Society of Great Britain and Ireland (http://www.pathsoc.org.uk/ meet/ prog.shtml).

Taylor, B., Miller, E., Farrington, C.P., Petropooulos, M.-C., Favot-Mayaud, I., Li, J. Waight, P.A. (1999a) ‘Autism and MMR vaccine: no epidemiological evidence for a causal association’, Lancet; 353: pp.2026–9.

Taylor, B., Miller, R., Farrington, C.P. (1999b) ‘MMR vaccination and autism’, (Correspondence: authors’ reply), Lancet; 354: p.950.

Uhlmann, V., Shiels, O., Wakefield, A.J., O'Leary, J. (2002) ‘Potential viral pathogenic mechanism for new variant IBD’, Journal of Clinical Pathology and Molecular Pathology; 55 (2): pp.84–90.

Wakefield, A.J., Montgomery, S.M. (2000) ‘MMR vaccine: through a glass darkly’, Adverse Drug Reactions and Toxicology Reviews; 19: pp.265–83.

Wakefield, A.J. (2001b) ‘Testimony of Dr Andrew J Wakefield before the Government Reform Committee of the US House of Representatives’, at http://www.unlockingautism.org/ testimonies/ index.

Wakefield, A.J. (2002b) Visceral, Press release, November, in response to Madsen et al. (2002) at http://www.visceral.org.uk.

Wakefield, A.J., Murch, S.M., Anthony, A., Linnell, J., Casson, D.M., Malik, M., Berelowitz, M., Dhillon, A.P., Thomson, M.A., Harvey, P., Valentine, A., Davies, S.E., Walker-Smith, J.A. (1998) ‘Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children’, Lancet; 351: pp.637–41.

Walker-Smith, J.A. (2003) ‘Enduring Memories: A paediatric gastroenterologist remembers’, London: The Memoir Club.

This completes Reading 1. Please click here to return to the main course.

S802_2

Take your learning further

Making the decision to study can be a big step, which is why you'll want a trusted University. The Open University has over 40 years’ experience delivering flexible learning and 170,000 students are studying with us right now. Take a look at all Open University courses.

If you are new to university level study, find out more about the types of qualifications we offer, including our entry level Access courses and Certificates.

Not ready for University study then browse over 900 free courses on OpenLearn and sign up to our newsletter to hear about new free courses as they are released.

Every year, thousands of students decide to study with The Open University. With over 120 qualifications, we’ve got the right course for you.

Request an Open University prospectus